Home›Stock Screener›Aurobindo Pharma›P/E Ratio

Aurobindo Pharma P/E Ratio

Current P/E Ratio
25.74
High Valuation
High - Growth expectations or overvalued

Aurobindo Pharma P/E ratio. Aurobindo Pharma (AUROPHARMA) P/E ratio is 25.74 (High), EPS (TTM) ₹60.34, current price ₹1578.80 on NSE vs historical average P/E of 16.78 (100.0th percentile) — High - Growth expectations or overvalued. Also explore AUROPHARMA share price history to track price trends across different timeframes.

Current Valuation Metrics

P/E Ratio 25.74
Current Price ₹1578.80
EPS (TTM) ₹60.34
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 16.78
Historical Range 4.98 - 22.54
Percentile 100.0%

Sector Context

Sector Average 54.97
Sector Median 32.04
Sector Rank #11 of 200
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹63.89
Mar 2026 ₹15.86
Jun 2026 ₹17.86

AUROPHARMA P/E Ratio — Valuation Signal & Historical Context

Aurobindo Pharma P/E 25.74 vs historical average 16.78, range 4.98–22.54 — signal: Overvalued. Examine Aurobindo Pharma quarterly financials for recent quarterly revenue, profit and EPS trends.

  • Stock appears overvalued with PE of 25.74, suggesting caution for new investments
  • Current PE is 53.4% above historical average
  • Trading at discount to sector average PE of 54.97

Aurobindo Pharma P/E Ratio Historical Trend

AUROPHARMA annual price-to-earnings ratio — 10 years, EPS and year-end price. Current P/E 25.74 vs historical average 16.78. For live price, revenue and the complete fundamental profile, see AUROPHARMA stock price BSE.

AUROPHARMA Historical P/E Ratio — EPS, Year-End Price & Valuation

Aurobindo Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 22.54 60.04 ₹1353.25 NSE Moderate
2024 18.07 59.76 ₹1080.15 NSE Moderate
2023 9.2 47.25 ₹434.80 NSE Low
2022 21.48 34.09 ₹732.10 NSE Moderate
2021 18.93 49.02 ₹927.75 NSE Moderate
2020 4.98 91.91 ₹458.10 NSE Low
2019 16.74 43.8 ₹733.15 NSE Moderate
2018 17.36 39.39 ₹683.95 NSE Moderate
2017 16.3 41.44 ₹675.50 NSE Moderate
2016 22.16 39.77 ₹881.40 NSE Moderate

AUROPHARMA vs Healthcare Peers — P/E Ratio Comparison

Aurobindo Pharma P/E 25.74 vs Healthcare average 54.97, median 32.04 — range 2.02–722.21.

Sector Average
54.97
Sector Median
32.04
Lowest P/E
2.02
Highest P/E
722.21
Companies
200
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.02 ₹60 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.33 ₹55 Low
Sun Pharma Advanced Rese… SPARC 3.86 ₹6,006 Low
Dipna Pharmachem DPL 3.97 ₹11 Low
JFL Life Sciences JFLLIFE 5.05 ₹65 Low
Royal Sense ROYAL 5.39 ₹40 Low
Kabra Drugs KABRADG 5.47 ₹41 Low
GKB Ophthalmics GKB 5.85 ₹32 Low
Colinz Laboratories COLINZ 6.31 ₹18 Low